These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease. Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140 [TBL] [Abstract][Full Text] [Related]
45. Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Liu W; Duan X; Xu L; Shang W; Zhao J; Wang L; Li JC; Chen CH; Liu JP; Tong C Cell Death Differ; 2020 Jun; 27(6):2014-2029. PubMed ID: 31907391 [TBL] [Abstract][Full Text] [Related]
46. CHCHD2 gene mutations in familial and sporadic Parkinson's disease. Shi CH; Mao CY; Zhang SY; Yang J; Song B; Wu P; Zuo CT; Liu YT; Ji Y; Yang ZH; Wu J; Zhuang ZP; Xu YM Neurobiol Aging; 2016 Feb; 38():217.e9-217.e13. PubMed ID: 26705026 [TBL] [Abstract][Full Text] [Related]
47. The 'mitochondrial contact site and cristae organising system' (MICOS) in health and human disease. Eramo MJ; Lisnyak V; Formosa LE; Ryan MT J Biochem; 2020 Mar; 167(3):243-255. PubMed ID: 31825482 [TBL] [Abstract][Full Text] [Related]
48. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease. Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156 [TBL] [Abstract][Full Text] [Related]
49. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1. Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756 [TBL] [Abstract][Full Text] [Related]
50. Frontotemporal Dementia-Related V57E Mutation Impairs Mitochondrial Function and Alters the Structural Properties of CHCHD10. Alici H; Uversky VN; Liu T; Kang DE; Woo JA; Coskuner-Weber O ACS Chem Neurosci; 2023 Jun; 14(11):2134-2145. PubMed ID: 37194187 [TBL] [Abstract][Full Text] [Related]
51. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature. Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936 [TBL] [Abstract][Full Text] [Related]
52. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients. Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991 [TBL] [Abstract][Full Text] [Related]
53. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria. Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905 [TBL] [Abstract][Full Text] [Related]
54. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease. Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516 [TBL] [Abstract][Full Text] [Related]
55. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J; Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311 [TBL] [Abstract][Full Text] [Related]
56. CHCHD2 mutational screening in Brazilian patients with familial Parkinson's disease. Voigt DD; Nascimento CM; de Souza RB; Cabello Acero PH; Campos Júnior M; da Silva CP; Pereira JS; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Della Coletta MV; da Silva DJ; Nicaretta DH; Gonçalves AP; Dos Santos JM; Calassara V; Santos-Rebouças CB; Pimentel MMG Neurobiol Aging; 2019 Feb; 74():236.e7-236.e8. PubMed ID: 30342766 [TBL] [Abstract][Full Text] [Related]
57. MNRR1, a Biorganellar Regulator of Mitochondria. Grossman LI; Purandare N; Arshad R; Gladyck S; Somayajulu M; Hüttemann M; Aras S Oxid Med Cell Longev; 2017; 2017():6739236. PubMed ID: 28685009 [TBL] [Abstract][Full Text] [Related]
58. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Wei Y; Vellanki RN; Coyaud É; Ignatchenko V; Li L; Krieger JR; Taylor P; Tong J; Pham NA; Liu G; Raught B; Wouters BG; Kislinger T; Tsao MS; Moran MF Mol Cancer Res; 2015 Jul; 13(7):1119-29. PubMed ID: 25784717 [TBL] [Abstract][Full Text] [Related]
59. PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila. Imai Y Neurosci Res; 2020 Oct; 159():40-46. PubMed ID: 32035987 [TBL] [Abstract][Full Text] [Related]
60. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation. Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]